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Exploring the association between Morgellons
disease and Lyme disease: identification of
Borrelia burgdorferi in Morgellons disease patients
Marianne J Middelveen1, Cheryl Bandoski2, Jennie Burke3, Eva Sapi2, Katherine R Filush2, Yean Wang3,
Agustin Franco3, Peter J Mayne1 and Raphael B Stricker1,4*
Abstract
Background: Morgellons disease (MD) is a complex skin disorder characterized by ulcerating lesions that have
protruding or embedded filaments. Many clinicians refer to this condition as delusional parasitosis or delusional
infestation and consider the filaments to be introduced textile fibers. In contrast, recent studies indicate that MD is
a true somatic illness associated with tickborne infection, that the filaments are keratin and collagen in composition
and that they result from proliferation and activation of keratinocytes and fibroblasts in the skin. Previously, spirochetes
have been detected in the dermatological specimens from four MD patients, thus providing evidence of an infectious
process.
Methods & Results: Based on culture, histology, immunohistochemistry, electron microscopy and molecular testing,
we present corroborating evidence of spirochetal infection in a larger group of 25 MD patients. Irrespective of Lyme
serological reactivity, all patients in our study group demonstrated histological evidence of epithelial spirochetal
infection. Strength of evidence based on other testing varied among patients. Spirochetes identified as Borrelia
strains by polymerase chain reaction (PCR) and/or in-situ DNA hybridization were detected in 24/25 of our study
patients. Skin cultures containing Borrelia spirochetes were obtained from four patients, thus demonstrating that
the organisms present in dermatological specimens were viable. Spirochetes identified by PCR as Borrelia burgdorferi
were cultured from blood in seven patients and from vaginal secretions in three patients, demonstrating systemic
infection. Based on these observations, a clinical classification system for MD is proposed.
Conclusions: Our study using multiple detection methods confirms that MD is a true somatic illness associated
with Borrelia spirochetes that cause Lyme disease. Further studies are needed to determine the optimal treatment
for this spirochete-associated dermopathy.
Keywords: Morgellons disease, Lyme disease, Borrelia burgdorferi, Spirochetes, Dermopathy
Background
Morgellons disease (MD) is a complex dermopathy char-
acterized by the spontaneous appearance of slowly-healing
skin lesions that contain multicolored filaments either
lying under, embedded in, or projecting from skin
(Figure 1A-C) [1-9]. Patients may also exhibit constitu-
tional, musculoskeletal and neurocognitive symptoms that
are associated with Lyme disease (LD) and tickborne
coinfections. The presence of these symptoms suggests
an infectious etiology of the dermopathy and possible
vectoring by ticks [4,7,8].
Previous studies found that MD patients demonstrate
seroreactivity to Borrelia burgdorferi (Bb) antigens and
multisystemic symptoms consistent with LD, suggesting
a spirochetal etiology [4,7,8]. In addition, histological, elec-
tron microscopic and PCR studies of dermatological tissue
containing filamentous inclusions from four MD patients
confirmed the presence of Bb sensu stricto spirochetes
[6,7]. Successful bacterial culture of motile spirochetes in
BSK-H medium inoculated with MD dermatological tissue
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demonstrated the viability of spirochetes in two of these
patients, and one culture was confirmed as Bb sensu
stricto by PCR analysis [7]. A case study of an MD patient
in Australia reported that endpoint PCR and Basic Local
Alignment Search Tool (BLAST) analysis resulted in the
detection and identification of Borrelia garinii [8]. These
preliminary studies suggest that MD may be a particular
manifestation of LD and that strains of Bb sensu stricto
and Bb sensu lato are implicated as etiologic agents [7,8].
In light of the preliminary studies indicating an associ-
ation of Lyme spirochetes with MD, we undertook a histo-
logical, electron microscopic and DNA study of North
American MD patients to investigate the presence of
borrelial spirochetes systemically and in dermatological
specimens. Culture was also undertaken to establish if spi-
rochetes detected in MD tissue were viable organisms and
to determine whether Borrelia infection in these patients
is systemic.
Methods
Patient selection
All patients included in this study met the key diagnostic
criterion documented by a healthcare provider: the pres-
ence of fibers that were visible underneath unbroken
skin or that were embedded in or projecting from skin.
Patients were selected from across Canada and the USA,
and they were included in the chronological order in
which they volunteered. No patients were excluded from
study participation provided that they had sample material
that was suitable for study and provided that they met the
diagnostic criterion. Written informed consent for partici-
pation in the study was obtained from all participants.
A B
C
Figure 1 Clinical features of Morgellons disease. A, MD patient back showing lesions covering entire surface, including areas out of patient’s
reach. B, Back of patient with scratching-induced lesions showing distribution limited to patient’s reach. C, Multicolored fibers embedded in skin
callus from MD Patient 2 (100x). B reproduced from Reference 19, used with permission of the publisher.
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Approval for sample collection was obtained from the
Western Institutional Review Board, Olympia, WA.
Further approval for sample testing was obtained from
the Institutional Review Board of the University of New
Haven, West Haven, CT.
A diagnosis of Lyme disease or positive Lyme serologic
testing prior to study participation was not a requirement.
Some patients had a prior Lyme diagnosis or serologic
testing for Lyme disease while others did not, as shown in
Table 1. Those who were not tested with Lyme serology
prior to the study were encouraged to be tested, but did so
after samples for the study had been collected. Some pa-
tients declined to have Lyme serologic testing performed.
Some of the subjects had received antibiotic therapy for
Lyme disease but were not receiving treatment during the
time of sample collection. Two subjects, 1 and 12, were
currently taking antibiotics during the time of sample
collection.
A total of 25 patients were included in the study. Pa-
tients 1-5 were previously presented as case studies [6,7,9].
Clinical patient data is shown in Table 1. All patient sam-
ples were deidentified and coded, and all laboratory testing
was performed in a blinded fashion.
Cultures
Borrelia culture medium was prepared using Barbour–
Stoner–Kelly H (BSK-H) complete medium with 6%
rabbit serum (Sigma Aldrich, #B8291) and the following
antibiotics: phosphomycin (0.02 mg/ml) (Sigma Aldrich),
rifampicin (0.05 mg/ml) (Sigma Aldrich), and amphotericin
Table 1 Clinical data for study patients
Patient # Age Gender Lyme serology Coinfecting tickborne diseases Antibiotic treatment
1 86 Female Positive Babesia microti, Bartonella henselae Treated at time of sampling
2 52 Female Positive Ehrlichia chaffeensis,Anaplasma
phagocytophilum
Previous treatment, but off at time of study
3 56 Female *Positive Not tested Never treated
4 75 Female *Positive Not tested Not treated at time of study
5 50 Male Equivocal Not tested Never treated
6 41 Male Positive Spotted fever group and typhus fever
group
Began treatment after start of study
7 51 Female *Positive Not tested Never treated
8 53 Female Positive Not tested Previous treatment, but off at time of study
9 35 Female Not tested Not tested Never treated
10 63 Female Positive Spotted fever group and Mycoplasma
spp. (Labcorp)
Not treated at time of study
11 47 Female *Positive Not tested Not treated at time of study
12 38 Male Positive None On antibiotic therapy during study
13 43 Female Positive Babesia spp. Treated but off antibiotics during study
14 53 Female *Positive Not tested Never treated
15 48 Female Clinical diagnosis,
not tested
Not tested Not treated at time of study
16 56 Female Not tested Not tested Never treated
17 62 Female *Positive Not tested Not treated at time of study
18 51 Female Not tested Not tested Never treated
19 75 Female **Positive Not tested Had 2 weeks treatment for Lyme but no treatment after
20 60 Female **Positive Not tested Had 3 weeks erythromycin after EM rash and + serology,
no treatment after
21 37 Female Positive Not tested Not treated at time of study
22 53 Female Not tested Not tested Not treated at time of study
23 68 Female Not tested Not tested Never treated
24 73 Female Not tested Not tested Never treated
25 58 Female ***Positive Not tested Never treated
All Lyme serology except that of patients 19, 20, and 25 tested and interpreted by IGeneX Reference Laboratories, Palo Alto, CA [10].
*Tested for B. burgdorferi after skin sampling was taken for study.
**Positive by 2-tiered CDC surveillance criteria.
***Tested by Spectracell Laboratories, Houston, TX.
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B (2.5 μg/ml) (Sigma-Aldrich), as described previously [11].
Inocula for blood cultures were prepared as follows: Ten
milliliters of whole blood were collected by venipuncture
and left at room temperature for 10 to 15 minutes to allow
clotting, followed by low speed centrifugation to separate
red blood cells. Serum and some blood cells just below the
serum layer were used as inocula. The serum/blood cell
preparation was inoculated into the BSK medium.
For other cultures, whole scabs removed from the pa-
tient, skin scrapings from small lesions removed by a
scalpel blade, or vaginal samples collected by swabbing
inside the vagina with a sterile cotton-tipped swab were
inoculated into the BSK medium. Cultures were incubated
in an Oxoid anaerobic jar (Thermo Scientific) containing
an AnaeroGen sachet (Thermo Scientific) to provide an
anaerobic environment at 32°C. Culture fluid samples
were examined by bright-field and/or dark-field micros-
copy for visible motile spirochetes weekly for up to
4 weeks. Cultures were processed for imaging and PCR
by centrifuging the fluid at 15,000 g for 20 minutes to
concentrate spirochetes, retaining the pellet and dis-
carding the supernatant.
Dieterle and anti-Bb immunostaining
Dermatological specimens and/or culture pellets from
patients were processed for specialized staining at either
McClain Laboratories LLC, Smithtown, NY; Interscope
Laboratories, Interscope Pathology Medical Group,
Canoga Park, CA; or the University of New Haven, West
Haven, CT. Dieterle silver-nitrate staining was performed
at either Interscope Laboratories or McClain Laboratories.
Anti-Bb immunostaining was performed at McClain
Laboratories or the University of New Haven.
For those samples submitted to McClain Laboratories
for anti-Bb immunostaining, the following protocol was
used: formalin-fixed, paraffin-embedded dermatological
tissue and culture pellets were sectioned and immuno-
stained using an unconjugated rabbit anti-Bb polyclonal
antibody (Abcam ab20950) and then incubated with an
alkaline phosphatase probe (Biocare Medical #UP536L)
followed by a chromogen substrate (Biocare Medical
#FR805CHC) and counterstained with hematoxylin. Posi-
tive and negative controls of both Dieterle and anti-Bb
immunostains were prepared for comparison purposes
using liver sections from uninfected mice and mice experi-
mentally inoculated with Bb, as previously described
[12]. Staining was titrated to define optimal antibody
dilutions. For comparison purposes, controls of culture
pellets from mixed Gram-positive bacteria and mixed
Gram-negative bacteria, and sections of normal human
skin were also examined to determine possible cross-
reactivity with commonly encountered dermatological
microorganisms.
For those samples submitted to the University of New
Haven, anti-Bb immunofluorescent staining was performed
as follows: formalin-fixed paraffin-embedded MD sections
were processed for staining and imaging as previously
described [13]. Dermatological specimens were formalin-
fixed, blocked in paraffin and sectioned by McClain La-
boratories. Culture fluid was fixed with acetone at -20°C
onto SuperFrost™ slides (Thermo Fisher Scientific,
Waltham, MA). Fixed specimens, both dermatological
sections and fixed culture fluid, were pre-incubated with
10% normal goat serum (Thermo Fisher Scientific) in PBS
containing 0.5% bovine serum albumin (BSA) (Sigma-
Aldrich, St. Louis, MO) for 30 minutes to block non-
specific binding of the secondary antibody. The slides
were then washed with PBS containing 0.5% BSA and
then incubated for 1 hour with fluorescein isothiocyan-
ate (FITC)-labeled Borrelia-specific polyclonal antibody
(Thermo Fisher Scientific, #73005) at a 1:50 dilution in
PBS containing 1% BSA pH 7.4 followed by washing
and then counterstained with 4’, 6-diamidino-2-pheny-
lindole (DAPI) for 10 minutes. For the negative control
samples, anti-specifically targeted antibody was replaced
with normal rabbit IgG (Vector Laboratories, Burlingame,
CA, #I–1000). Images were obtained using fluorescent
microscopy.
Electron microscopy
Samples for scanning electron microscopy (SEM) and trans-
mission electron microscopy (TEM) were forwarded to the
Electron Microscopy Facility, Department of Materials Sci-
ence and Engineering, Clemson University, Anderson, South
Carolina. Procedures were performed as previously de-
scribed [6,7].
For SEM, culture pellets, fixed in buffered 2.5% glu-
taraldehyde were washed in buffer and dehydrated in
a graded series of ethanol concentrations, followed by
immersion in hexamethyldisilazane for 5–15 minutes
and then air-dried at room temperature. Dry samples
were mounted on Al mounts and were not coated but
placed into a Hitachi TM3000 microscope (Tokyo,
Japan) and imaged in the variable pressure mode.
For TEM, glutaraldehyde-fixed samples were washed in
buffer and dehydrated in a graded series of ethanol con-
centrations. Samples were immersed in a 50:50 mixture of
LR White embedding resin and 100% ethanol for 30 mi-
nutes, followed by pure LR White resin until they settled
on the bottom of the vial. Resin-immersed samples were
placed into pure resin in beam capsules and polymerized
at 60°C overnight. Sections were cut on an Ultracut E
microtome (Leica Microsystems, Wetzlar, Germany) pro-
ducing sections 60–90 nm thick, and were placed onto
copper grids then stained in uranyl acetate for 20 minutes.
Imaging was performed using a Hitachi 7600 microscope.
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Molecular testing
PCR - University of New Haven
DNA was extracted from culture pellets and/or derma-
tological tissue by lysing overnight in 180 μl tissue lysis
buffer (Qiagen) and 20 μl Proteinase K (Qiagen) at 56°C
in a shaking water bath and phenol:chloroform extraction
the following day. DNA was resuspended in 50-100 μl 1X
TE buffer.
A published TaqMan assay targeting a 139-bp fragment
of the gene encoding the Borrelia 16S rRNA was used for
the detection of Borrelia in DNA extracted from patient
samples [14]. Reactions were carried out in a final volume
of 20 μl and consisted of 900 nM of each primer, 200 nM
of probe, and 10 μl of 2X TaqMan Universal PCR Master
Mix (Applied Biosystems). Amplifications were carried
out on a CFX96 Real-Time System (Bio-Rad) and cycling
conditions consisted of 50°C for 2 minutes, 95°C for 10 mi-
nutes, followed by 40 cycles of 95°C for 15 seconds and
60°C for 60 seconds. Fluorescent signals were recorded
using CFX96 Real-Time software and Cq threshold was
set automatically. Reactions were performed in triplicate.
Positive and negative controls were run simultaneously.
The positive control was Bb sensu stricto strain B-31. Four
negative controls were used: water, normal human fore-
skin, normal skin from two Lyme patients, and normal
skin from one Morgellons patient. Borrelia DNA was not
detected in any of the negative controls.
Nested PCR primers for the 16S rRNA, flagellin (Fla),
OspC, uvrA and pyrG genes were used as previously
described [15-17]. Reactions were carried out in a final
volume of 50 μl using 10 μl template DNA. Final con-
centrations were 2X Buffer B (Promega), 2 mM MgCl2,
0.4 mM dNTP mix, 2 μM of each primer, and 2.5 U
Taq polymerase (Invitrogen). “Outer” primers were used
in the first reaction. “Inner” primers were used for the
nested reaction, in which 1 μl of PCR product from the
first reaction was used as template for the second. Cycling
parameters were as follows: 94°C for 5 minutes followed
by 40 cycles of denaturation at 94°C for 1 minute, anneal-
ing for 1 minute (temperature based on the primer set
used), and extension at 72°C for 1 minute, with a final
extension step at 72°C for 5 minutes. PCR products
were visualized on 1-2% agarose gels.
Sanger sequencing was used for gene analysis. PCR prod-
ucts were extracted from the agarose gels using the QIA-
quick Gel Extraction kit (Qiagen) according to the
manufacturer’s instructions. The eluates from each sample
were sequenced in both directions using the primers that
generated the products. Obtained sequences were compared
by searching the GenBank database (National Center for
Biotechnology Information) using BLASTanalysis. Sequence
alignment (Clustel W) and neighbor-joining phylogenetic
analyses were conducted using MEGA version 5. Tree sup-
port was evaluated by bootstrapping with 500 replications.
PCR - Australian biologics
Dermatological specimens and/or culture pellets were
concentrated by centrifugation and stabilized with AL
buffer (Qiagen). Samples were forwarded to Australian
Biologics for Borrelia detection by real-time PCR target-
ing the 16S rRNA gene and endpoint PCR targeting the
rpoC gene, as previously described [8,18]. The Eco™
Real-Time PCR system with software version 3.0.16.0
was used. DNA was extracted from the dermatological
specimens and the culture pellets using the QIAamp
DNA Mini Kit (Qiagen). Samples were analyzed in du-
plicate with positive and negative controls using primers
for the Borrelia 16S rRNA and rpoC gene targets, as
previously described [8,18]. Thermal profiles for all ana-
lyses were performed with incubation for 2 minutes at
50°C, polymerase activation for 10 minutes at 95°C then
PCR cycling for 40 cycles of 10 secs at 95°C dropping to
60°C sustained for 45 secs. The magnitude of the PCR
signal generated (ΔR) for each sample was interpreted as
either positive or negative as compared to positive and
negative controls.
PCR products were visualized on 1-2% agarose gels and
extracted from the gels using the QIAquick Gel Extraction
kit (Qiagen) according to the manufacturer’s instructions.
Sanger sequencing was used for gene analysis, as described
previously [18].
Bb molecular beacons
Dr. Alan MacDonald designed the DNA sequences and
generously donated the Bb molecular beacon DNA probes.
Probe FlaB, a sequence of 23 nucleotides, was derived from
the Bb open reading frame (ORF) BB0147 of the flagellin B
gene that contains more than 1000 nucleotides. A nucleo-
tide BLAST search of the 23 nucleotide probe sequence
disclosed no matches other than that of Bb BB0147. Probe
740 was derived from the Bb ORF BB740 representing a
Bb inner cell membrane protein, and a nucleotide BLAST
search disclosed no matches other than that of the Bb ORF
BB740.
Bb DNA staining and detection with molecular beacons
was performed by the following protocol, as previously de-
scribed [12]. Paraffin sections of dermatological specimens
and culture pellets were completely dewaxed by baking at
60°C then immersed in serial 100% xylene baths, followed
by serial immersion through 100% ethanol, 90% ethanol,
80% ethanol and distilled H2O, then air-dried. Fixed
sections were immersed in 20 μl of working DNA bea-
con solution. Sectioned specimens were covered with
plastic cut from a Ziploc® freezer bag then were heated
at 90°C for 10 minutes to denature all DNA and RNA.
Heat was reduced to 80°C for 10 minutes, then samples
cooled gradually to room temperature. The stained slides
were washed in PBS, and covered with 30% glycerol
and a glass coverslip, then examined under an EPI Fluor
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microscope. Staining of research specimens was performed
alongside staining of positive and negative controls. Posi-
tive controls consisted of a known Bb strain embedded in
agarose, formalin-fixed and sectioned, as well as experi-
mentally Bb-infected mouse liver sections. The negative
control consisted of uninfected mouse liver sections.
Results
Histological examination – dermatological specimens
All patients were clinically diagnosed with MD by a
healthcare provider based on the presence of skin lesions
and/or skin crawling sensations with intradermal fila-
ments that were visible with a hand-held microscope, as
described in previous publications [4-9]. The dermato-
logical material that met our diagnostic criterion was
mainly in the form of calluses embedded with filaments,
many of which were blue or red. MD calluses were easily
removed from patients as they were composed of thick-
ened skin that has separated from the dermis at the
stratum basale. Histological examination of cross sections
revealed epidermal layers from the stratum basale to the
stratum corneum. In MD calluses, collagen and keratin fil-
aments could be seen distributed throughout the epider-
mal tissue or projecting down from the stratum basale
towards the dermis.
Dermatological specimens consisting of callus material
from the following patients were submitted for histo-
logical sectioning and examination: 1-4, 8, 10-13, 15, 16,
18-20, 22, 23, 25. Biopsy sections were submitted for
histological examination for patient 24. Sections of hair
follicular bulbs and attached follicular sheaths rather
than sectioned calluses were submitted for patient 5.
Samples from patients 6, 7, 9, 14, 17 and 21 were used
for culture and/or PCR detection only.
All histological sections were examined at 400X and
1000X magnification. In slides stained with Dieterle sil-
ver nitrate stain and/or anti-Bb antibodies, sectioned
filaments embedded in epithelial cells were observed in
samples of all callus material and in the biopsy material
from patient 24. All filaments demonstrated the same
morphology: a hollow medulla surrounded by a solid cor-
tex. Filamentous material demonstrated no characteristics
consistent with fungal elements such as hyphae, or any
characteristics of known parasites such as microfilariae.
Dieterle silver nitrate staining revealed bacteria mor-
phologically consistent with Borrelia spirochetes in 17/19
patients (Table 2). Positively-stained spirochetes were
observed in dermatological sections from the specimens
submitted for patients 1-4, 8, 10-13, 15, 16, 18, 19, 20, 22
and 23 (Figure 2A). No spirochetes were observed for pa-
tients 5 or 24. Patient 5 had only sectioned follicular bulbs
and sheaths submitted and patient 24 had biopsy sections
submitted. These biopsy sections demonstrated bacterial
forms consistent with cystic variants of Bb.
Anti-Bb immunohistochemical staining was reactive in
all the histological sections of dermatological specimens
submitted including the follicles and follicular sheaths
from patient 5 and the two biopsy sections from patients
24 and 25 (100%). Individual spirochetes were discern-
ible in many of these specimens (Figure 2B). Staining of
Bb spirochetes was positive in infected mouse liver
samples. There was no significant Bb immunostaining
of the Bb-negative mouse liver control, the mixed Gram-
positive bacterial pellet or normal human skin. Staining of
sections of mixed Gram-negative bacteria from the Gram-
negative culture pellet showed only weak background
staining. In control studies of the anti-Bb immunostaining
performed at the University of New Haven, the antibody
reacted with Bb but not with Treponema denticola.
Bb spirochetes in a callus specimen from patient 2
were detected by SEM and on sectioned calluses from
patients 1 and 2 by TEM as previously reported [6].
Culture – general observations
Cultures were performed on skin, blood and/or vaginal
specimens taken directly from patients 3, 4, 6-9, 13, 14,
17, 21 and 24. Motile viable organisms were observed in
all cultures at 4 weeks of incubation except for the skin
culture taken from patient number 6. Motile organisms
displayed morphological variation, ranging from spherules
to longer helical-shaped bacteria. None of the specimens
could be subcultured onto blood agar, even in anaerobic
conditions, and there was no contamination by commonly
encountered aerobic Gram-positive bacteria. Some of the
cultures had very few organisms, and documentation of
growth by photography was difficult because of mor-
phological variation. Some cultures were therefore con-
centrated by centrifugation and stained with Dieterle
silver nitrate stain and anti-Bb immunostain for further
characterization.
Skin culture
Dermatological specimens were submitted for culture from
patients 3, 4, 6, 9, 13 and 21. Examination of culture fluid
at 4 weeks incubation revealed motile spirochetes, except
for the culture from patient 6. The culture from patient 9
revealed little growth, but one long motile spirochete was
observed. Dieterle silver nitrate staining of skin cultures
was performed on specimens from patients 3, 6, and 13.
These specimens demonstrated positive staining of both
spherules and spirochetes consistent with morphological
forms of Borrelia. All specimens demonstrated strongly
positive Bb polyclonal immunostaining of the bacteria
present as well as the surrounding cellular debris. This
may have been due to secreted exoantigens, antigens
released by lysed Bb, or the presence of Bb intracellular
infection. Data is summarized in Table 3.
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The culture fluid from patient 6 did not reveal motile
spirochetes, so to ascertain the presence of spirochetes a
centrifuged culture pellet was submitted for SEM. SEM
revealed that spirochetes with morphological features
consistent with Bb were present in the culture pellet
(Figure 2C).
Blood culture
Blood specimens for culture were taken from patients 3,
4, 7, 8, 13, 14, 17 and 24. Motile bacteria with spiro-
chetal morphology were observed in culture fluid from
the eight patients. Dieterle silver nitrate staining and
anti-Bb immunostaining was performed on blood cul-
tures concentrated by centrifugation from these patients.
Patients 3, 7, 8, 13 and 17 demonstrated positive staining
of both spirochetes and spherules consistent with mor-
phological forms of Borrelia with Dieterle silver nitrate
staining. These patients also demonstrated strongly posi-
tive Bb immunostaining of the bacteria in the samples
as well as the surrounding cellular debris, as described
above. Data is summarized in Table 3.
Vaginal culture
Swabs of vaginal secretions were submitted for culture
from patients 8, 14, 21 and 24. Motile bacteria were visible
in culture fluid from all four patients. Staining of vaginal
cultures concentrated by centrifugation followed by Diet-
erle silver nitrate staining and anti-Bb immunostaining
was performed for specimens taken from patients 8 and
21. Both specimens demonstrated positive staining of both
spherules and spirochetes consistent with morphological
forms of Borrelia with Dieterle silver nitrate stain. Both
specimens demonstrated strongly positive Bb immuno-
staining of the bacteria in the samples as well as the
surrounding cellular debris, as described above. Data is
summarized in Table 3.
Molecular testing
A. PCR Detection of Borrelia
Various sample types from 20 patients were submitted
for PCR detection of Borrelia at three independent la-
boratories. These samples included whole dermatological
calluses, histological skin sections, skin culture, blood
culture, vaginal cultures, and one specimen of intestinal
Table 2 Microscopic examination of dermatological tissue sections with Dieterle or Warthin Starry silver nitrate stain
and anti-Bb polyclonal immunostain
Patient # Dieterle Bb-polyclonal immunostain Filaments morphologically
consistent with MD
1 Spirochetes observed *Positive Detected
2 Spirochetes observed *Positive Detected
3 Spirochetes observed *Positive Detected
4 Spirochetes observed *Positive Detected
5 Spirochetes not observed **Positive Detected
8 Spirochetes observed Positive Detected
10 Spirochetes observed Positive Detected
11 Spirochetes observed Positive Detected
12 Spirochetes observed Positive Detected
13 Spirochetes observed Positive Detected
15 Spirochetes observed Positive Detected
16 Spirochetes observed Positive Detected
18 Spirochetes observed Positive Detected
19 Spirochetes observed Positive Detected
20 Spirochetes observed Positive Detected
22 Spirochetes observed Positive Detected
23 Spirochetes observed Positive Detected
24 Spherules consistent with Bb
morphological variants observed
Positive Detected
25 Spirochetes observed Positive Detected
Dieterle and or Warthin-Starry silver nitrate staining performed at Interscope Laboratories, Los Angeles, CA, and or McClain Laboratories, Smithtown, NY.
Bb polyclonal immunostaining performed at McClain Laboratories.
*Polyclonal Bb immunostaining performed at University of New Haven, West Haven, CT and McClain Laboratories.
**Sectioned specimen consisted of hair follicular bulbs with attached root sheaths rather than skin. Polyclonal Bb immunostaining performed at the University of
New Haven.
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epithelial tissue that had sloughed off in the patient’s feces
during an intestinal cleanse. Borrelia genes were detected
in 18 of the patients whose samples were submitted, and
results were equivocal for 2 patients. Amplicon sequences
consistent with Borrelia DNA were obtained for the PCR
products from 14 patients. Bb sensu stricto sequence was
confirmed in 12 patients, while patient 23 was found to
have an amplicon sequence consistent with B. miyamotoi
and patient 24 had a sequence consistent with B. garinii.
The latter patient had contracted Lyme disease in Europe.
Positive PCR results are summarized in Table 4.
Skin cultures from patients 6, 9, 13 and 21 were sub-
jected to PCR testing, and three of the four samples tested
positive, confirming the presence of Borrelia in the cul-
tures. The fourth culture sample (patient 21) had equivo-
cal PCR testing using the 16S rRNA probe but tested
positive using the FlaB molecular probe (see below).
Thus molecular testing confirmed the presence of viable
Borrelia spirochetes in all four skin culture samples.
Treponema denticola was detected in 5/16 scab/callus
samples sent to Australian Biologics. T. denticola was
not detected in any blood, skin or vaginal cultures (data
not shown).
B. In-situ DNA hybridization
Bb DNA was detected by staining with the fluorescent
molecular probes FlaB and 740. Histological sections of
callus material from patients 2, 3, 10, 11, 13, 15, 19, 20,
22 and sections of skin and/or vaginal culture pellets from
patients 21 and 24 were stained with the FlaB probe. All
these specimens were positively stained (Figure 2D).
Histological sections of callus material from patients 1-4,
8, 10-13, 15, 16, and 18-20, and sections of the skin
culture from patient 6 and blood culture from patient
7 were stained with probe 740. All of these specimens
were positively stained. The results are summarized in
Table 5.
A B
C D
Figure 2 Evaluation of skin samples from Morgellons disease patients. A, Dieterle silver stain of skin sample from MD Patient 15 showing
dark-staining spirochetes (1000x). B, Immunostaining of spirochete with anti-Bb antibody in skin sample from MD Patient 4 (1000x). C, Scanning
electron micrograph of skin culture sample from MD Patient 6 showing wavy spirochetes (arrows). D, Hybridization of Bb-specific molecular beacon
FlaB with spirochetes in skin sample from MD Patient 3 (400x).
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Discussion
Despite compelling evidence to the contrary, MD continues
to be attributed to delusions of parasitosis or delusional in-
festation [19-23]. The earlier studies demonstrating Borrelia
spirochetes in MD dermatological specimens have involved
only a small number of study subjects, and therefore a
study involving a larger number of subjects was needed.
A major strength of our study is that MD patients
were identified based on the presence of multicolored fi-
bers within skin lesions or detectable under unbroken skin.
Some of our patients did suffer from neuropsychiatric
symptoms, and we do not deny that primary delusional in-
festation can occur in rare cases [1-4]. By selecting only
MD patients meeting our dermopathy criterion, however,
we have presumably excluded primary delusional infest-
ation patients from our study. Although some MD patients
suffering from neuropsychiatric symptoms with Borrelia-
associated intradermal filaments may claim to have worms,
parasites or the like, the skin crawling and stinging sensa-
tions that these patients feel coupled with visible skin
lesions, anxiety and anthropomorphic thinking may re-
sult in complaints that are misinterpreted by clinicians
as a primary delusional disorder. Other MD patients in
our study had no neuropsychiatric symptoms and yet
had the same Borrelia-associated dermopathy, so it appears
that in our well-defined MD patient cohort these symp-
toms, when they occurred, were the result rather than the
cause of the infectious dermopathy, as previously described
[1-4,23].
We have provided evidence linking Borrelia infection
with MD in a study group consisting of 25 patients. We
detected Borrelia DNA by PCR and/or staining with Bb-
specific DNA probes in 24/25 patients. We were able to
demonstrate the presence of Borrelia in dermatological
tissue and we were able to culture viable Bb spirochetes
from skin, blood and vaginal secretions in some patients.
The presence of spirochetes was confirmed by numerous
testing methodologies, including culture, histology, anti-
Bb immunostaining, electron microscopy, PCR and in
situ Bb DNA hybridization. Laboratory testing method-
ologies were performed at five independent laboratories.
Histological staining and electron microscopy of Morgel-
lons dermatological tissue and cultures was performed
at three different laboratories, while molecular testing
for Borrelia was performed at three different laboratories
using real-time PCR, nested PCR and in situ Bb DNA
hybridization. Furthermore, Borrelia DNA amplicon se-
quencing was conducted at two different laboratories.
We have thus provided corroborating evidence of Borrelia
infection in MD patients that should be difficult to refute.
Recent studies reported similarities between MD and
bovine digital dermatitis (BDD), a disease that is com-
mon in dairy herds [5,9]. BDD is characterized by skin
lesions that commonly occur on and directly above the
Table 3 Microscopic examination of sectioned culture pellets with Dieterle or Warthin Starry silver nitrate stain and
anti-Bb polyclonal immunostain
Patient # Inoculum type Culture fluid Dieterle Bb polyclonal immunostain*
3 Skin Motile spirochetes Spirochetes Positive**
3 Blood Motile bacteria Spirochetes Positive
4 Skin Motile spirochetes Not submitted Not submitted
4 Blood Motile bacteria Not submitted Not submitted
6 Skin*** Little growth observed Spirochetes Positive
7 Blood Spherules Spherules Positive
8 Blood Spherules Spirochetes Positive
8 Vaginal Motile spherules Spherules Positive
9 Skin Little growth, single long motile spirochete Not submitted Not submitted
13 Skin Spherules/motile elongated bacteria Spirochetes/ spherules Positive
13 Blood Spherules Spirochetes/ spherules Positive
14 Blood Spherules Not submitted Not submitted
14 Vaginal Motile spirochetes Not submitted Not submitted
17 Blood Spherules Spirochetes/ spherules Positive
21 Skin Spherules/ spirochetes Not submitted Not submitted
21 Vaginal Motile spherules Spherules Positive
24 Blood Spherules/ Motile bacteria Not submitted Not submitted
24 Vaginal Motile spirochetes Not submitted Not submitted
*Anti-Bb immunostaining performed at McClain Laboratory, Smithtown, NY, except for the skin culture from patient 3.
**Anti-Bb immunostaining performed at the University of New Haven, West Haven, CT.
***SEM revealed well-defined spirochetes with periplasmic flagella.
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heel bulb of the hind feet of cattle [24,25]. Chronic BDD
lesions demonstrate proliferative keratin filaments, and
histological examination of diseased tissue reveals spiro-
chetes identified as Treponema spp. dispersed among
enlarged keratinocytes throughout the stratum spinosum
and dermal papillae [26-30]. Though spirochetes are
consistently detected in tissue from lesions, coinvolve-
ment of other bacterial pathogens has been proposed as
a contributing etiologic factor [27,28,31,32]. Treponemal
spirochetes were confirmed as the primary etiologic agents
when the condition was duplicated via experimental infec-
tion with pure cultured treponemes [33,34].
As with BDD, MD filaments are not textile fibers. MD
fibers are biofilaments of human cellular origin produced
by epithelial cells and stemming from deeper layers of
the epidermis and the root sheath of hair follicles [5,9].
Immunohistochemical and histological staining has dem-
onstrated that these multicolored filaments are composed
of collagen and keratin [6,9]. They are nucleated at the
base of attachment to adjacent epithelial cells, and the
cells at the filament base are continuous in appearance
with the surrounding skin cells [6]. Although the cause of
coloration of red fibers has not been defined, the blue
coloration is the result of melanin pigmentation rather
than a dye, as shown by Fontana Masson histological
staining [6]. There are no known textile fibers that are
collagen in composition, nucleated at their base of at-
tachment, or pigmented blue with melanin. Thus the
Table 4 Detection of Borrelia DNA by PCR in samples derived from Morgellons patients
# Specimen PCR University of New Haven PCR Australian Biologics Sequencing
1 Whole callus pyrG, fla, ospC 16S rRNA pyrG, fla, ospC
2 Whole callus pyrG, fla, 16S rRNA 16S rRNA pyrG
3 Whole callus fla, pyrG, 16S rRNA, uvrA, ospC 16S rRNA 16S RNA, pyrG, fla, uvrA, ospC
3 Blood culture fla
4 Callus section 16S rRNA
4 Blood culture fla
5 Whole callus pyrG 16S rRNA pyrG
6 Skin culture 16S rRNA
7 Blood culture fla
8 Whole callus pyrG, 16S rRNA, fla pyrG, fla,
8 Blood culture fla, pyrG fla
9 Skin culture fla fla
10 Whole callus 16S rRNA, pyrG, fla 16S rRNA 16S rRNA, pyrG
10 Intestinal specimen 16S rRNA
11 Whole callus fla+/- indeterminate Inhibited
13 Whole callus uvrA uvrA
13 Blood culture pyrG 16S rRNA
13 Skin culture pyrG
14 Blood culture fla 16S rRNA fla
14 Vaginal culture fla 16S rRNA fla
15 Whole callus 16S rRNA
16 Whole callus rpoC rpoC
17 Whole callus pyrG, uvrA 16S rRNA pyrG, uvrA
17 Blood culture Real-time 16S rRNA +/- equivocal
18 Whole callus fla 16S rRNA fla
21 Skin culture 16S rRNA +/- equivocal
23 Whole callus 16S rRNA rpoC*
24 Blood culture fla 16S rRNA
24 Vaginal culture 16S rRNA rpoC**
*Sequence consistent with B. miyamotoi.
**Sequence consistent with B. garinii.
Amplicon sequences from all patients were consistent with Bb sensu stricto except for sequence from patient 23, which was consistent with B. miyamotoi, and
patient 24, which was consistent with B. garinii.
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characteristic fibers in MD are clearly distinct from tex-
tile fibers [6].
Histological sections of MD dermatological tissue reacted
with anti-Bb immunostain in 19/19 of the dermatological
specimens submitted for histological examination. Motile
Borrelia spirochetes were cultured in medium inoculated
with skin scrapings from 4 patients, thus demonstrating
that Borrelia spirochetes in MD lesions are viable. Borrelia
spirochetes were also detected in blood cultures from some
MD patients in our study, confirming systemic Lyme borre-
liosis. Spirochetes characterized as strains of Borrelia were
detected by PCR and/or in situ DNA hybridization in tissue
or culture specimens from 24/25 patients; 15 of these
patients had Borrelia gene products detected in derma-
tological specimens and/or skin cultures taken from
MD lesions, and DNA amplicons from 14 patients were
sequenced and confirmed to be Borrelia strains. Vaginal
secretions from four patients were cultured, and three
isolates were identified as Borrelia strains by PCR and
in situ DNA hybridization.
Lyme borreliosis is a systemic infection that is commonly
associated with dermatological manifestations [35]. Given
that most MD patients are serologically reactive to Bb anti-
gens, the presence of Lyme spirochetes in MD dermato-
logical lesions is predictable and supports an etiologic role
of the spirochetal disease. Bb sensu stricto and Bb sensu
lato have been associated with numerous dermatological
manifestations including erythema migrans, borrelial lym-
phocytoma, acrodermatitis chronica atrophicans, morphea,
lichen sclerosus, cutaneous B-cell lymphoma, scleroderma,
lymphadenosis cutis and prurigo pigmentosa [35-38]. Like-
wise it appears that MD is associated with Lyme disease in
a subgroup of patients with this spirochetal illness [6-8]. It
is possible that spirochetes other than Bb sensu stricto and
the Bb sensu lato complex, such as the agent of syphilis,
Treponema pallidum, could be responsible for similar
manifestations in other patients. In support of this sup-
position, Ekbom’s original 1945 description of delusions
of parasitosis reported that many of the patients in that
study were diagnosed with syphilis, thus linking trepo-
nemal infection with pruritus, crawling sensations and
belief of infestation [39]. Furthermore, treponemal spi-
rochetes have been shown to induce the formation of
filamentous lesions in animal models [26-30].
The mechanism of filament formation in MD is not yet
elucidated. The filaments are composed of keratin and
collagen and arise from proliferative keratinocytes and fi-
broblasts in human epithelial tissue [6,9]. Bb appears to
have a predilection for fibroblasts and keratinocytes, and
invasion of these cells by Borrelia spirochetes has been
reported [40-42]. Bb appears to attach to fibroblasts
followed by engulfment of the spirochetes, formation of
vacuoles and intracellular replication [42]. Intracellular
sequestration of Bb in skin fibroblasts and keratinocytes
may protect the spirochetes from host defense mecha-
nisms [40,41]. It is therefore reasonable to hypothesize
that Bb intracellular infection of keratinocytes and fibro-
blasts may alter keratin and collagen expression and that
the presence of Borrelia spirochetes in dermatological tis-
sue is a primary etiologic factor in the evolution of MD
lesions.
Viable Bb spirochetes have been isolated from lysates
of fibroblast and keratinocyte monolayers treated with
antibiotics [40,41]. Therefore, in addition to protection
from host defenses, sequestration within fibroblasts and
keratinocytes may protect Bb from antibiotic therapy. Spi-
rochetes in MD dermatological tissue from Patients 1 and
12 were reactive to anti-Bb immunostains and we detected
Borrelia DNA in dermatological tissue taken from these
two patients. These patients were receiving aggressive
antibiotic therapy at the time of this study. Patients 2, 8,
13, 19 and 20 had previously received antibiotic therapy
for Lyme disease, yet still had detectable spirochetal in-
fection. Persistent infection refractory to antibiotic treat-
ment may therefore result from sequestration of Borrelia
spirochetes within keratinocytes and fibroblasts in MD
patients.
Although spirochetes appear to be the primary etio-
logic agents of MD, evidence suggests that the etiology
Table 5 Detection of Bb DNA by in situ hybridization with
Bb-specific DNA probes in samples derived from Morgellons
patients
Patient # Specimen Probe FlaB Probe 740
1 Callus Not performed Positive
2 Callus Positive Positive
3 Callus Positive Positive
4 Callus Not performed Positive
6 Skin culture Not performed Positive
7 Blood culture Not performed Positive
8 Callus Not performed Positive
10 Callus Positive Positive
11 Callus Positive Positive
12 Callus Not performed Positive
13 Callus Positive Positive
15 Callus Positive Positive
16 Callus Not performed Positive
18 Callus Not performed Positive
19 Callus Positive Positive
20 Callus Positive Positive
21 Skin culture Positive Not performed
21 Vaginal culture Positive Not performed
22 Callus Positive Not performed
24 Biopsy Positive Not performed
Middelveen et al. BMC Dermatology  (2015) 15:1 Page 11 of 14
is multifactorial. Secondary etiologic factors, such as
female predominance, immune dysfunction, and other
tickborne coinfections appear to play a role in the de-
velopment of this dermopathy [1-5]. As noted in Table 1,
we found serological evidence of tickborne coinfections
including Babesia, Anaplasma, Ehrlichia, Bartonella and
Rickettsia spp. in five of six patients who were tested. The
role of these coinfections in MD remains undefined.
Although we demonstrated the presence of Borrelia
spirochetes in all of the patients in our study group, T.
denticola was detected in dermatological specimens
from five patients. The role of these commonly occurring
oral spirochetes in the evolution of MD dermatological le-
sions and subsequent filament formation is uncertain, and
we speculate that coinvolvement of these and perhaps
other pathogens could be contributing or exacerbating
factors in MD.
A study from the Centers for Disease Control and Pre-
vention (CDC) concluded that pathogens were not in-
volved in MD [22]. The search for spirochetal pathogens
in that study was limited to Warthin-Starry staining on a
small number of tissue samples and commercial two-tiered
serological Lyme disease testing as interpreted by the CDC
Lyme surveillance criteria [22]. It should be noted that only
two of the patients in our study group were positive for
Lyme disease based on the CDC Lyme surveillance criteria
and yet Borrelia spirochetes were readily detectable in this
group of 25 MD patients.
The diagnosis of Lyme disease is a controversial topic
in the medical literature. Serological tests for Lyme disease
lack sensitivity, and seronegativity has been demonstrated
in patients with Bb infection [43,44]. PCR detection is not
standardized, and sensitivity and specificity of testing
therefore varies from laboratory to laboratory [45,46]. We
detected Borrelia strains using different primers and dif-
ferent methodologies, and our findings show that primer
hybridization differed between samples. Likewise Borrelia
antigen detection may be unreliable, and immunostaining
may lack sensitivity or specificity [46,47]. Although our
dermatological and culture pellet sections were consist-
ently reactive with anti-Bb polyclonal antibodies, we were
not certain of the specificity of our testing. We wish to
emphasize, however, that repeated detection of Borrelia
spirochetes using a combination of diverse laboratory
methods makes false-positive testing highly unlikely in
these MD patients.
Borrelia culture is not available in many laboratories
and can be challenging because of fastidious growth re-
quirements and spirochetal pleomorphism [48,49]. The
formation of spherical forms, truncated forms, straight
forms, wavy forms and the like could result in positive
cultures being overlooked. Our cultures demonstrated
significant pleomorphism, and cystic or truncated vari-
ants were present, more so in blood cultures than skin
cultures. In our experience histological identification is
complicated because pleomorphism occurs in vivo as well
as in vitro [50,51]. Sensitivity and specificity differences
between laboratory methodologies to detect Borrelia
spirochetes necessitate the use of several different method-
ologies to confirm the presence of Borrelia infection. If MD
is determined to be pathognomonic for Lyme borreliosis it
will aid in the diagnosis of Lyme disease in this group of pa-
tients. A recent study from Australia found MD in 6% of pa-
tients diagnosed with Lyme disease on that continent [52].
We achieved a high degree of success in detecting Bb
and closely-related spirochetes from MD dermatological
tissue. We attribute our success to several key factors.
First, as stated previously we had a clear diagnostic cri-
terion that allowed us to select the appropriate clinical
cohort. Second, in contrast to T. pallidum, the treponemal
agent of syphilis, Borrelia spp. can be cultured, thereby
magnifying their numbers in vitro and increasing the
opportunity for detection. Third, unlike secondary and
tertiary syphilitic skin lesions where treponemes are
seldom detected, we observed that MD lesions carry a
high spirochetal load that allows for relatively easy de-
tection, similar to lesions seen in cattle with BDD. Finally,
we used a variety of sensitive microscopic and molecular
methodologies to detect Borrelia spp., including molecular
hybridization and PCR techniques that can detect spiro-
chetal DNA in the picogram range.
The detection of Borrelia spirochetes in dermatological
samples from a larger group of MD patients further vali-
dates the infectious nature of this dermopathy. As noted
above, T. pallidum spirochetes are seldom detected in
secondary and tertiary syphilitic skin lesions, even when
sensitive molecular techniques such as PCR are per-
formed, yet syphilis spirochetes are acknowledged to be
the causative agent of these lesions [53-55]. The use of
a clinical classification system for syphilis has helped
with diagnosis and treatment of this systemic treponemal
infection. In contrast to syphilis, we were able to consist-
ently isolate and/or detect Borrelia spirochetes from MD
dermatological specimens. Also in contrast to syphilis, no
clinical classification system exists for MD.
Based on our experience with several hundred MD pa-
tients, we propose a clinical classification scheme that re-
flects the duration and location of MD lesions, as follows:
1. Early localized: lesions/fibers present for less than
three (3) months and localized to one area of the
body (head, trunk, extremities).
2. Early disseminated: lesions/fibers present for less
than three (3) months and involving more than one
area of the body (head, trunk, extremities).
3. Late localized: lesions/fibers present for more than
six (6) months and localized to one area of the body
(head, trunk, extremities).
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4. Late disseminated: lesions/fibers present for more
than six (6) months and involving more than one
area of the body (head, trunk, extremities).
The classification scheme provides a medical framework
that should help to validate and standardize the diagnosis
of MD. Further studies are needed to determine whether
this classification will have therapeutic and prognostic sig-
nificance for MD patients.
Conclusions
We undertook a detailed microscopic and molecular
study of North American MD patients to investigate the
presence of borrelial spirochetes systemically and in der-
matological specimens. Based on culture, histology, im-
munohistochemistry, electron microscopy and molecular
testing, we present extensive evidence for spirochetal in-
fection in MD patients. Our study confirms that MD is a
true somatic illness associated with Lyme disease. The
proposed clinical classification scheme for MD should aid
in the diagnosis and treatment of this complex illness.
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